Findings
depressive disorder, depression
SECONDARY
In this pooled secondary analysis of data from the US Food and Drug Administration that included 57 313 participants with severe depression from 232 randomized clinical trials of antidepressants for major depressive disorder, all quantiles of depression response were more favorable among drug-assigned participants, by 3% to 14%. These findings depend heavily on statistical assumptions.